Objective: To describe the main characteristics of systematic reviews addressing questions of chronic disease and related risk factors for Indigenous Australians.
I
n 2008, the Council of Australian Governments (COAG) committed to addressing the health disparity between Aboriginal and Torres Strait Islander peoples (hereafter Indigenous Australians) and non-Indigenous Australians by adopting the Closing the Gap policy initiative. 1 Targets were set for a range of health and wellbeing indicators including life expectancy and child mortality. 2 While funding for specific government monitoring of Closing the Gap has been withdrawn, there has been some government investment in monitoring and evaluating programs targeting improvements in these indicators. The data show progress in reducing Indigenous child mortality and early improvements in rates of immunisation. However, they show little improvement in achieving equitable health outcomes, and wide disparities remain. 2 For example, the life expectancy gap between Indigenous and non-Indigenous Australians is estimated to be 10.6 years for males and 9.5 years for females. 2 This raises the concern that current Closing the Gap initiatives will be insufficient to achieve the equity targets. 3 Chronic diseases underpin about 70% of the Indigenous/non-Indigenous life expectancy gap. 4, 5 They share a number of common underlying lifestyle risk factorsnotably poor nutrition -and factors such as physical inactivity, alcohol misuse and tobacco smoking, and are influenced by the social determinants of health. 4, 5 The main diseases responsible are diabetes, chronic kidney disease, cardiovascular disease and respiratory disease. 4 The risk factors for chronic disease are disproportionally higher among Indigenous Australians, who are more likely to have multiple risk factors with cumulative adverse effects. 2 Providing decision makers working in policy formulation and health services with the best available evidence about opportunities to prevent, and enhance treatment and management of, chronic disease for Indigenous Australians is important to promote health equality. Systematic review is widely recognised by clinicians and government policy decision makers as a key step to guide them towards best practice healthcare. 6 Initially, systematic reviews were limited to synthesis of evidence from randomised controlled trials (RCTs) addressing questions about health treatment efficacy. 6 However, the methodology has evolved; reviewers now have access to best practice guidance for systematic review of evidence from diverse study designs and even expert opinion, to inform decisions about health treatment and policy. [7] [8] [9] The empirical and theoretical literature on knowledge translation in health highlights the importance of reviewers and users -including clinicians, health managers and policy makers -working together to define review objectives and evidence implementation activities to ensure reviews are useful.
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The ethical conduct of primary research with Indigenous Australians has received much attention as reflected by various national 12 and local 13,14 guidelines. Practical guides and principle statements 15 have been developed to raise understanding among primary researchers about the ethical obligations that the national and local guidelines/standards impose on them, and to ensure they abide by them. 16 Conversely, there is little literature on how to conduct ethically appropriate rigorous systematic review research, and no guidelines, principles or reporting standards to support best practice systematic review of evidence gathered with Indigenous Australians.
In 2009, the public health group within Cochrane conducted a project 17 that sought to identify gaps in the international evidence relevant to public health decision making to address health inequalities experienced by Indigenous people, and to identify priority areas and topics for future reviews. A number of participating Indigenous researchers and clinicians expressed reservations about the appropriateness and value of conventional systematic reviews of intervention evidence to Indigenous health. 17 One participant expressed the view that improving the quality of Indigenous health intervention research was a greater priority than conducting systematic reviews. Some taskforce members cautioned that prioritising topics for systematic reviews according to criteria such as burden of disease was problematic in that it was too "biomedical" in its approach and would downplay the important role of the social determinants of health in leading to poor health and social outcomes. 17 Ensuring that systematic review methods for Indigenous health research meet the needs of those that use them, including Indigenous communities themselves, emerged from this project as a key area for future research. 17 Applying the rigorous processes used to identify and appraise evidence in systematic review, in this overview, we locate and describe the main characteristics of existing, systematic reviews addressing questions about chronic diseases and their risk factors, prevalence and management within the Indigenous Australian population. The intent is to assist in building a program of systematic review research that synthesises evidence the right way and generates valid, relevant findings that help improve chronic disease and other health outcomes for Indigenous Australians.
Methods

Inclusion criteria
Population
• Indigenous Australians (systematic reviews whose study participants were Indigenous people from Australia, United States, Canada and New Zealand if they reported results separately for Indigenous Australians).
Chronic diseases
• Cardiovascular disease (including ischemic heart disease and stroke); chronic kidney (renal) disease; chronic liver disease (including alcoholic liver disease); chronic respiratory disease (including COPD and asthma); type 2 diabetes mellitus; depression; and cancers related to smoking, alcohol and poor nutrition (lung, larynx, oropharynx, bladder, mouth, lip, tongue, nose, nasal, sinus, cervix, ureter, bone marrow, pancreas, stomach, bowel, breast, endometrium, kidney, oesophagus, colon, liver, pharynx).
Risk factors
• The main lifestyle risk factors for chronic disease: tobacco smoking, excessive alcohol consumption, physical inactivity and poor diet (nutrition).
Systematic review
• Clearly stated review objective(s)/ question(s) addressing prevalence, prevention, treatment and/or management of one or more of the chronic diseases or risk factors considered.
• Clearly defined inclusion criteria.
• Reported search strategy.
• Presentation of synthesised findings for the stated review question(s) including but not limited to narrative and tabular synthesis. Scoping reviews and systematic reviews of reviews were not considered for inclusion. 
Search and study selection
Assessment of methodological quality
In the absence of a tool designed specifically to appraise systematic reviews and other syntheses of research involving Indigenous Australians, we used a modified version of the Joanna Briggs Institute Critical Appraisal Checklist for Systematic Reviews and Research Synthesis. 18 Two reviewers independently assessed each review (JSG, KC). Disagreements were resolved through discussion. Reviews were classified as high (compliance with all 11 quality items in the appraisal tool), good (7-10 items) or moderate (6 or less) quality.
Data extraction and analysis
Two reviewers (JSG, KC) extracted data using a predefined data extraction tool developed specifically for this review and designed to extract data on key characteristics of systematic reviews. Each reviewer crosschecked data extraction for 20% of the studies (randomly selected) for completeness and accuracy. 
Results
Study selection
We identified a total of 3,568 records from the databases searched ( Figure 1 ). 
Methodological quality
All of the included reviews 19-32 met four of the 11 quality criteria in the checklist (1-4 of the criteria in Table 1 ), as the systematic review inclusion criteria required that they be met. We rated three of the included reviews as high quality (11 20 Chang et al 2011 21 Clifford et al 2011 22 Minges et al 2011 23 Thompson et al 2011 24 Carson et al 2012 25 Ospina et al 2012 26 Porter et al 2012 27 Clifford et al 2013 28 Gould et al 2013 29 Gould et al 2013 30 Lee et al 2013 31 Rich et al 2013 32 1. Screening of titles and abstracts 1 942
Identified by expert/peer reviewer 1 • Evidence suggests IHW involvement improves outcomes but small sample prevents strong conclusion
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• Practice of including IHW in asthma education programs for Indigenous children and adults with asthma is justified, unless data suggest otherwise.
• Additional high quality primary research required 20 None of the reviews explained the rationale for the date limitations applied.
Characteristics of included studies
There was wide variation in the types of studies considered for inclusion in the identified reviews. For example, in the reviews examining intervention effectiveness, two considered only experimental evidence, 21, 26 while four included a broader range of study designs and mixed (quantitative and qualitative) evidence, 20, 28, 29, 31 and one included quantitative evidence from mixed study designs. 22 The majority of the reviews 25, 26 used narrative and tabular synthesis plus meta-analysis. One review used a metaethnographic synthesis method. 30 The limited use of statistical meta-analysis should not be seen as a weakness, as small samples and heterogeneity of included studies precluded the conduct of useful meta-analysis in most reviews.
Only three systematic reviews 20, 22, 31 reported taking steps to align the review process with Indigenous Australian research values or/and capture Indigenous specific knowledge (see Table 2a -c).
Discussion
We identified 14 systematic reviews examining evidence for one or more question(s) about chronic disease prevalence, risk factors, treatment and management for Indigenous Australians. The small number indicates that systematic review has been under-used to date as a tool for improving Indigenous Australian chronic disease outcomes. Rapid growth in the number of systematic reviews published in recent years is an encouraging trend.
Two considerations were consistent when considering findings of the included systematic reviews. The first was the small number of included studies, many of which were assessed as moderate to poor quality. This resulted in most reviewers cautioning that poor quality and/or limited evidence prevents drawing strong conclusions and evidence-based recommendations for policy and/or practice. Related to this, most reviewers raised the need for additional high quality research, both intervention and focused on understanding risk factor or disease prevalence. The second observation was that of differences in the results for different population sub-groups (e.g. different age cohorts, females compared to males) and geographical settings (e.g. remote versus urban) of the reviews addressing questions about prevalence of risk factors or diseases.
The small number of systematic reviews synthesising evidence pertinent to intervention effectiveness is of particular concern in light of the need for evidence on what works, what does not and why. We identified additional reviews addressing questions about intervention effectiveness but these were excluded at full text examination for not meeting the minimum method requirements for systematic review. Of the 25 articles reviewed and excluded at full text, 18 (72%) examined evidence relating to intervention effectiveness (see the supplementary file, available online). This raises the importance of distinguishing the need for more reviews from the need for more high quality reviews.
The definition of systematic review used in this overview was lax rather than strict. It did not require that reviewers conduct and report critical appraisal using a validated tool.
International guidance for the conduct of systematic reviews presents critical appraisal as a key step in the review process because it identifies potential sources of bias in the evidence base, and helps reviewers interpret the evidence correctly and draw appropriate recommendations. 6, 7 Had completion of critical appraisal and assessment of risk of bias been in the inclusion criteria for this overview, only nine reviews 19, 21, 22, 25, 26, [28] [29] [30] [31] would have been included. Another methodological weakness identified in a portion (30%) of the systematic reviews was failure to include databases using specialist indexing tools designed to capture studies conducted with Indigenous Australians and search for grey literature.
The identified characteristic of widespread inclusion of mixed (quantitative and qualitative) evidence in the identified reviews is positive, as literature on Indigenous research methodology identifies oral evidence and sharing knowledge through story telling/yarning as key to understanding. 34, 35 The identified reviews' limited consideration of expert opinion is a weakness, as contextual and cultural knowledge from local Indigenous community representatives/experts is identified by leading Indigenous researchers as key to deriving valid policy/practice recommendations about intervention options to improve Indigenous health outcomes. 17 The scope of health conditions focused on in the set of identified systematic reviews appears narrow and sub-optimal when viewed against the range of chronic diseases affecting Indigenous Australians.
Methodological priorities
This overview raises three methodological priorities to support ethically appropriate, rigorous and relevant systematic reviews about questions relating to chronic disease and other health issues for Indigenous Australians. The first is raising awareness among reviewers and users of evidence synthesis about the rationale for, and value of, critical appraisal. This is important because reviews that summarise the evidence without careful and appropriate consideration of the risk of bias in the primary studies using tools relevant to the study design of the evidence they synthesise run the risk of developing conclusions and practice (or policy) recommendations that are not valid. The second methodological priority is the need for reviewers to use comprehensive search strategies that seek grey and commercial literature and cover databases known to be key repositories of studies conducted with Indigenous Australians.
The third methodological priority is the need for research and consultation to develop method guidance, tools (including for critical appraisal) and reporting standards for best practice systematic review of evidence gathered with Indigenous Australians that is informed by ethical standards/guidelines for conducting research with Indigenous Australians [12] [13] [14] [15] [16] and Indigenous perspectives on ways of constructing knowledge. 34, 35 There are at least five reasons why this is important.
1) The national and local guidelines governing research involving Indigenous Australians [12] [13] [14] [15] [16] impose an obligation on the research community to consider whether current systematic review guidance and practice is congruent with ethical standards and take steps to adjust it where not.
2) Development and use of systematic review method guidance informed by the key principles in the guidelines/standards 12-16 is likely to promote relevance and benefit of systematic reviews for Indigenous Australians. This is because the guidelines [12] [13] [14] [15] [16] include the requirements that researchers consult with community representatives prior to conducting research to ensure research questions are informed by the community's identified needs and that Indigenous community representatives and researchers are involved in and benefit from the research.
3) The validity of systematic review findings is undermined by failure to adjust systematic review methods to consider and incorporate oral evidence and opinion from Indigenous community representatives/experts (e.g. on cultural and contextual factors), which literature on Indigenous methodology 34, 35 and Indigenous researchers 17 have clarified is important. 4) Use of critical appraisal tools that do not incorporate criteria informed by Indigenous perspectives on ethically appropriate and rigorous research means that reviews present only a partial understanding of strengths and limitations of the existing evidence base. 5) Absence of such guidance, tools and reporting standards makes it likely that resources are wasted on reviews that are of limited relevance to and have little benefit for Indigenous Australians.
Priority questions for systematic reviews -the need for reviewers to engage with users
The small number of systematic reviews identified focused on smoking, asthma and diabetes, suggesting there is still a wide array of questions to synthesise evidence for to inform better chronic disease prevention, treatment and management. Reviewers should be guided by community priorities to decide which review questions should be addressed. Reviewers must also consult with clinicians and other decision makers, including policy makers, working in health services aimed at improving chronic disease outcomes for Indigenous Australians. 10, 11 At a practical level, this requires that reviewers view consultation, partnership building and priority setting as part of the review process, and funds need to be invested in this.
Limitations
One limitation of this overview is that the methodological quality of included reviews was judged using a critical tool designed for studies in any population, not specifically Indigenous Australian populations. A second limitation is the narrow scope of the chronic disease risk factors considered. This is particularly important to highlight in light of the need to synthesise evidence for decision makers on effective measures to address the social determinant of Indigenous Australians poor health outcomes. 17 A third limitation is that we are aware of at least two other soon-to-be-published systematic reviews that would have met all the inclusion criteria, but were not included due to the search date limit (31 December 2013). Including these two reviews would not have altered the profile of the main characteristics of the systematic reviews presented or priorities for the research agenda. A final limitation is that by excluding reviews that did not meet the inclusion criteria, this review excluded a number of additional reviews (see supplementary file) that have addressed questions about chronic disease prevalence, risk factors and management in the Indigenous Australian population.
Conclusion
There has been considerable investment in research and interventions to improve chronic disease and other health outcomes of Indigenous Australians. They have been among the most researched populations in the world. 17 Despite this, much of the published material is of relatively poor quality and cannot be translated directly into benefits for communities. The majority of Indigenous Australians continue to suffer dismal health outcomes. The research community, including individuals focused on both primary and secondary research involving Indigenous Australians, has an obligation to Indigenous people in Australia to improve the way they do their research.
Over the past decade, a number of guidelines for ethical best practice research with Indigenous Australians have emerged [12] [13] [14] [15] [16] and have been used by ethics committees reviewing primary research proposals. This overview raises the importance of not only ethically appropriate primary research but also more rigorous primary research on intervention effectiveness. It identifies development and dissemination of consensus and expert-based method guidance, tools and reporting standards to support ethically appropriate, high-quality and relevant systematic review as a priority. In the absence of such guidance, we offer some suggestions about what is required of systematic reviewers, based on considering ethical guidelines for primary research involving Indigenous Australians [12] [13] [14] [15] [16] and Indigenous Australian research expert opinions. 17 We suggest that at a minimum reviewers should: 1) align review objectives/questions with communityidentified priorities and decision-making needs of individuals working in health services and/or policy, which may require investing in partnership building and priority setting; 2) include and be guided by Indigenous community representatives in review teams; 3) consider mixed evidence and expert opinion from relevant Indigenous contextual and cultural experts; 4) supplement conventionally used criteria with criteria informed by Indigenous standards for ethically appropriate and rigorous research in critical appraisal; 5) conduct a comprehensive search that is capable of identifying studies published in commercial and grey literature; 6) together with community, plan for and take actions to ensure Indigenous people benefit from reviews, which could include activities to translate the review findings into better health policy and/or practice.
